header
Local cover image
Local cover image
Image from OpenLibrary

The correlation between Fas, Fas ligand and interleukin 12 in determination of the response to interferon treatment in Egyptian patients infected with hepatitis C virus / Doaa Mohamed Mahomud Abdelmaksoud ; Supervised Ahmed Ibrahim Amin , Amal Ahmed Mohamed , Raafat Zaher Abdelrahman

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Doaa Mohamed Mahomud Abdelmaksoud , 2014Description: 163 P. : charts , facsimiles ; 25cmOther title:
  • العلاقة بين الفاس: الفاس ليجاند و الأنترلوكين - ١٢فى تحديدٌ الأستجابة للعلاج بالانترفيرون فى المرضى المصرين المصابين بالفيرس الكبدى الوبائى سى [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry Summary: Hepatitis means inflammation of the liver. The most common hepatitis viruses are types A, B, and C. Hepatitis C virus (HCV) related liver disease is a common and clinically significant condition. It is considered to be one of the most common chronic viral infections worldwide. The prevalence of HCV infection varies across the world, with the highest number of infections reported in Egypt. The current standard of care therapy for chronic HCV infection consists of a combination of pegylated (PEG) interferon (IFN - Ü 2a) and ribavirin. In some cases the treatment with INF (IFN-Ü 2a) and ribavirin failed and the case become relapse so we need new markers to predict the response to treatment. In our study we have interkeukine 12 (IL - 12), Fas and Fas ligand markers as predictors for IFN response
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.02.M.Sc.2014.Do.C (Browse shelf(Opens below)) Not for loan 01010110064596000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.02.M.Sc.2014.Do.C (Browse shelf(Opens below)) 64596.CD Not for loan 01020110064596000

Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry

Hepatitis means inflammation of the liver. The most common hepatitis viruses are types A, B, and C. Hepatitis C virus (HCV) related liver disease is a common and clinically significant condition. It is considered to be one of the most common chronic viral infections worldwide. The prevalence of HCV infection varies across the world, with the highest number of infections reported in Egypt. The current standard of care therapy for chronic HCV infection consists of a combination of pegylated (PEG) interferon (IFN - Ü 2a) and ribavirin. In some cases the treatment with INF (IFN-Ü 2a) and ribavirin failed and the case become relapse so we need new markers to predict the response to treatment. In our study we have interkeukine 12 (IL - 12), Fas and Fas ligand markers as predictors for IFN response

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image